| Financial Year |
March 31 2023 |
| Monetary Funds |
96,216,399.50 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
305,425,257.11 |
| Advances to Suppliers |
34,361,041.77 |
| Other Receivables |
46,783,186.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
109,870,253.61 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,612,960.59 |
| Total Current Assets |
594,269,099.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
239,181,261.73 |
| Under-construction Projects |
8,641,000.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
11,552,277.48 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,381,040.74 |
| Deferred Income Tax Assets |
58,165,663.36 |
| Other Non-Current Assets |
2,512,392.93 |
| Sub-Total of Non-Current Assets |
329,396,106.70 |
| Total Assets |
923,665,206.21 |
| Short-Term Loans |
169,047,973.60 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,491,550.31 |
| Accounts Payable |
133,758,213.09 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,339,008.80 |
| Taxes Payable |
1,610,189.14 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
17,839,032.66 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,630,550.49 |
| Other Current Liabilities |
166,605.08 |
| Sub-Total of Current Liabilities |
344,164,700.70 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,772,635.85 |
| Special Payable |
-- |
| Estimatied Liabilities |
5,445,000.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,683,178.61 |
| Total Liabilities |
354,847,879.31 |
| Paid-In Capital(Or Share Stock) |
405,673,777.00 |
| Capital Surplus |
538,780,670.15 |
| Surplus Reserve |
18,464,838.85 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-415,501,027.32 |
| Minority Stockholder's Interest |
21,859,138.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
546,958,188.32 |
| Owner's Equity（Stockholder's Equity） |
568,817,326.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
923,665,206.21 |
